Edition:
United Kingdom

PLx Pharma Inc (PLXP.OQ)

PLXP.OQ on NASDAQ Stock Exchange Capital Market

4.60USD
17 Sep 2018
Change (% chg)

-- (--)
Prev Close
$4.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,527
52-wk High
$9.40
52-wk Low
$3.05

Chart for

About

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325... (more)

Overall

Beta: 1.85
Market Cap(Mil.): $55.17
Shares Outstanding(Mil.): 8.69
Dividend: --
Yield (%): --

Financials

  PLXP.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -8.18 -- --
ROI: -54.02 1.78 14.61
ROE: -75.17 3.29 16.33

BRIEF-PLx Pharma Q4 Loss Per Share $0.90

* Q4 REVENUE $340,000 Source text for Eikon: Further company coverage:

23 Mar 2018

Earnings vs. Estimates